查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363162

臨床前影像市場規模、佔有率、趨勢分析報告：按產品、用途、最終用途、地區和細分市場進行預測，2023-2030 年

Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Services, Ultrasound Imaging), By Application (Research and Development, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

臨床前影像市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球臨床前影像市場規模預計將達到 59.5 億美元。

預計2023年至2030年該市場將以4.74%的年複合成長率成長。對研發的大量投資正在推動世界各地的研究項目。因此，對臨床前成像的需求正在穩步成長。製藥、生物技術、生命科學、醫療設備和化妝品是成像模式廣泛用於研發的應用領域。此外，獸醫院和教育機構也在這個市場創造新的需求。

核子醫學技術（主要是正子斷層掃描（PET）和單光子發射電腦斷層掃描（SPECT））、光學影像、顯微電腦斷層掃描（CT）、磁振造影（MRI）、光聲斷層掃描（PAT）、超音波，是最重要的技術。適用於小動物體內影像用途的模式。每種方式都有其自身的優點和缺點。旨在提供有關正在研究的病理學過程的補充資訊的多模態設備正在迅速普及，旨在克服每種成像模態的固有限制。高解析度模式（例如微型 CT 和微型 MRI）與提供功能資訊的高靈敏度技術（例如微型 PET 和微型 SPECT）相結合，可用於感染疾病、腫瘤、循環系統、神經系統疾病預計它不僅能夠拓寬關鍵領域的研究範圍，有助於理解疾病的基本機制，能夠提供一個高效率、統一的工具。

我們提供高效、統一的工具來評估新藥和候選藥物，推動全球市場成長。

全球市場的主要競爭正在採取各種配合措施豐富產品系列，包括推出新產品和提高製造能力。例如，在2023年2月舉行的第75屆印度放射影像協會上，富士軟片印度公司宣布了設備和服務的開發。該公司於 2023 年 2 月 2 日至 5 日在阿姆利則舉行的活動中展示了其尖端的診斷工具。最近推出的 MRI 機 APERTO Lucent 非 DICOM 印表機 APEOS 和超音波診斷設備Arietta 650 DeepInsight 和 Arietta 850 DeepInsight 都是新產品組合的結構要素。此外，還發布了智慧型手機應用程式「FUJIFILM Connect」。

此外，用於癌症研究和監測應用的高通量超音波成像系統的進步將推動市場發展。 2022 年 4 月，PerkinElmer 宣布擴展即時影像分析，以加速癌症、腎臟病、肝病、心臟病等領域的非侵入性臨床研究和藥物研發。我們推出了 Vega，一款手持式超音波成像系統，具有完全自動化技術和高吞吐量能力。鼓勵使用非侵入性影像方法，因為它們減少了侵入性手術的需要，同時最大限度地減少了動物的不適。出於這種倫理考慮，臨床前影像技術被採用。

臨床前成像市場報告亮點

  • 按產品，光學成像領域由於在小動物成像和藥物發現項目中的廣泛使用，在 2022 年佔據最大的收益佔有率，為 13.6%。
  • 按用途來看，由於技術進步和醫療基礎設施的改善，研發領域在2022年佔據了最大的銷售佔有率，為54.93%。
  • 以最終用途分類，製藥和生物技術領域在 2022 年佔據最大收益佔有率，達到 40.19%。製藥和生物技術公司持續的研究活動和產品創新正在導致市場參與者的產品銷售增加並推動市場成長。
  • 按地區分類，北美在 2022 年佔據最大收益佔有率。這是要素發達的研究基礎設施、大量的臨床前項目以及技術先進設備的高採用率。
  • 該行業的主要企業正在專注於引入先進的技術和能力，例如由人工智慧支援的系統。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 臨床前影像市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 產業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 臨床前影像市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略聯盟分析
    • 打入市場策略

第4章 臨床前影像市場：按產品分類的估計和趨勢分析

  • 定義和範圍
  • 2018年及2030年產品市場佔有率
  • 細分儀表板
  • 按產品的臨床前影像市場預測
  • 2018年至2030年市場規模、預測與趨勢分析

第5章 臨床前影像市場：按用途估計和趨勢分析

  • 定義和範圍
  • 2018年及2030年用途市場佔有率
  • 細分儀表板
  • 按用途分類的臨床前影像市場預測
  • 2018年至2030年市場規模、預測與趨勢分析

第6章 臨床前影像市場：最終用途的估計和趨勢分析

  • 定義和範圍
  • 2018年及2030年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的臨床前影像市場預測
  • 2018年至2030年市場規模、預測與趨勢分析

第7章 臨床前影像市場：區域估計與趨勢分析

  • 2020 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2020年區域市場佔有率和主要企業
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 要素因素（政治/法律、經濟/技術）進行 SWOT 分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030 年市場規模、預測、數量與趨勢分析：
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • 創新者
  • 供應商形勢
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2022 年主要市場佔有率分析
    • Bruker Corporation
    • Siemens Healthineers AG
    • GE Healthcare
    • TriFoil Imaging
    • PerkinElmer, Inc.
    • VisualSonic Inc.（Fujifilm）
    • Mediso Ltd.
    • Agilent Technologies
    • MR Solutions
    • MILabs BV
    • Molecubes
Product Code: 978-1-68038-881-7

Preclinical Imaging Market Growth & Trends:

The global preclinical imaging market size is anticipated to reach USD 5.95 billion by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 4.74% from 2023 to 2030. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

Nuclear medicine techniques (primarily, positron emission tomography (PET) and single photon emission computed tomography (SPECT)), optical imaging, micro-computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT), and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality. The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the global market growth.

The global market's prominent competitors are undertaking different initiatives for enhancing their product portfolio with novel product launches and enhancing their manufacturing capacity. For instance, In February 2023, at the 75th National Conference of the Indian Radiological and Imaging Association, FUJIFILM India announced the development of its equipment and service offerings. The company demonstrated cutting-edge diagnostic tools at the event in Amritsar from February 2-5, 2023. The recently released MRI machine APERTO Lucent Non DICOM printer APEOS and the ultrasound devices Arietta 650 DeepInsight and Arietta 850 DeepInsight are all components of the new portfolio. A smartphone application for assistance and guidance called "FUJIFILM Connect" was additionally released by the company.

Moreover, the advancements in the high-throughput ultrasound imaging system used in the application of cancer research and studies boost the market. In April 2022, the Vega imaging system, a handheld ultrasound system with fully automated technology and high-throughput capacity, which can speed up non-invasive clinical research and drug discovery in the fields of cancer, kidney and liver disease, and heart disease, was launched by PerkinElmer as an aspect of the company's announcement of a broadening of its live image analysis. The use of non-invasive imaging methods is encouraged since they reduce the need for invasive operations while minimizing animals' discomfort to a minimum. Preclinical imaging techniques have been adopted as a result of this ethical consideration.

Preclinical Imaging Market Report Highlights:

  • Based on product, the optical imaging segment held the largest revenue share of 13.6% in 2022 owing to its wide usage in small animal imaging and new drug discovery projects
  • In terms of application, the research and development segment held the largest revenue share of 54.93% in 2022 owing to the technological advancements and improved healthcare infrastructure
  • In terms of end-use, the pharma and biotech companies segment held the largest revenue share of 40.19% in 2022. The constant research activities and innovation of products in pharma & biotech companies have led market players to increase their product sales, driving market growth
  • Based on region, North America held the largest revenue share in 2022 owing to the well-developed research infrastructure, a large number of preclinical projects, and higher adoption rates of technically advanced devices in the region can be attributed to this share
  • Major players in the industry are focusing on the launch of advanced technology and features such as artificial intelligence-enabled systems

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Technological advancements
      • 3.4.1.2. Growing number of investments and funding in research and development
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Strict regulatory framework
  • 3.5. Preclinical Imaging Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Preclinical Imaging Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. CT Imaging
    • 4.1.2. MRI Imaging
    • 4.1.3. PET/SPECT Imaging
    • 4.1.4. Multi-modal Imaging
    • 4.1.5. Optical Imaging
    • 4.1.6. Ultrasound Imaging
    • 4.1.7. Photoacoustic Imaging
    • 4.1.8. Reagents
    • 4.1.9. Services
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Preclinical Imaging Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. CT imaging
      • 4.5.1.1. CT imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. MRI imaging
      • 4.5.2.1. MRI imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. PET/SPECT imaging
      • 4.5.3.1. PET/SPECT imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Multi-modal imaging
      • 4.5.4.1. Multi-modal imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.5. Optical imaging
      • 4.5.5.1. Optical imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.6. Ultrasound imaging
      • 4.5.6.1. Ultrasound imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.7. Photoacoustic imaging
      • 4.5.7.1. Photoacoustic imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.8. Reagents
      • 4.5.8.1. Reagents imaging market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.9. Services
      • 4.5.9.1. Services market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Research and Development
    • 5.1.2. Drug Discovery
  • 5.2. Application Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Preclinical Imaging Market by Application Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Research and Development
      • 5.5.1.1. Research and development market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Drug Discovery
      • 5.5.2.1. Drug discovery market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Preclinical Imaging Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Pharma and Biotech Companies
    • 6.1.2. Research Institutes
    • 6.1.3. Others
  • 6.2. End-use Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Preclinical Imaging Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Pharma and Biotech Companies
      • 6.5.1.1. Pharma and biotech companies market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Research Institutes
      • 6.5.2.1. Research institutes market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Others
      • 6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2020 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2020
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Europe
    • 7.8.1. UK
      • 7.8.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Germany
      • 7.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. France
      • 7.8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.4. Italy
      • 7.8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.5. Spain
      • 7.8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.6. Sweden
      • 7.8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.7. Norway
      • 7.8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.8. Denmark
      • 7.8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Japan
      • 7.9.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. China
      • 7.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. India
      • 7.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. South Korea
      • 7.9.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.5. Australia
      • 7.9.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.6. Thailand
      • 7.9.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.9.6.2.
  • 7.10. Latin America
    • 7.10.1. Brazil
      • 7.10.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.2. Mexico
      • 7.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.3. Argentina
      • 7.10.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11. MEA
    • 7.11.1. Saudi Arabia
      • 7.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.2. South Africa
      • 7.11.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.3. UAE
      • 7.11.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.4. Kuwait
      • 7.11.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2022
    • 8.3.4. Bruker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Siemens Healthineers AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. GE Healthcare
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. TriFoil Imaging
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. PerkinElmer, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. VisualSonic Inc. (Fujifilm)
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Mediso Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Agilent Technologies
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. MR Solutions
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. MILabs B.V.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Molecubes
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America preclinical imaging market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe preclinical imaging market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Germany preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 23 France preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 24 France preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Denmark preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific preclinical imaging market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 45 China preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 46 China preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 51 India preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 52 India preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Australia preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America preclinical imaging market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 64 Latin America preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Brazil preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa preclinical imaging market, by region, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Africa preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait preclinical imaging market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait preclinical imaging market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait preclinical imaging market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Preclinical imaging market: market outlook
  • Fig. 14 Preclinical imaging market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Preclinical imaging market driver impact
  • Fig. 20 Preclinical imaging market restraint impact
  • Fig. 21 Preclinical imaging market strategic initiatives analysis
  • Fig. 22 Preclinical imaging market: product movement analysis
  • Fig. 23 Preclinical imaging market: product outlook and key takeaways
  • Fig. 24 CT market estimates and forecast, 2018 - 2030
  • Fig. 25 MRI market estimates and forecast, 2018 - 2030
  • Fig. 26 PET/SPECT market estimates and forecast, 2018 - 2030
  • Fig. 27 Multi-Modal market estimates and forecast, 2018 - 2030
  • Fig. 28 Optical market estimates and forecast, 2018 - 2030
  • Fig. 29 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 30 Photoacoustic market estimates and forecast, 2018 - 2030
  • Fig. 31 Reagents market estimates and forecast, 2018 - 2030
  • Fig. 32 Services market estimates and forecast, 2018 - 2030
  • Fig. 33 Preclinical imaging market: application movement analysis
  • Fig. 34 Preclinical imaging market: application outlook and key takeaways
  • Fig. 35 Research and development market estimates and forecast, 2018 - 2030
  • Fig. 36 Drug discovery market estimates and forecast, 2018 - 2030
  • Fig. 37 Preclinical imaging market: end-use movement analysis
  • Fig. 38 Preclinical imaging market: end-use outlook and key takeaways
  • Fig. 39 Pharma and biotech companies market estimates and forecast, 2018 - 2030
  • Fig. 40 Research institutes market estimates and forecast, 2018 - 2030
  • Fig. 41 Others market estimates and forecast, 2018 - 2030
  • Fig. 42 Global preclinical imaging market: regional movement analysis
  • Fig. 43 Global preclinical imaging market: regional outlook and key takeaways
  • Fig. 44 Global market shares and leading players
  • Fig. 45 North America market share and leading players
  • Fig. 46 Europe market share and leading players
  • Fig. 47 Asia Pacific market share and leading players
  • Fig. 48 Latin America market share and leading players
  • Fig. 49 Middle East & Africa market share and leading players
  • Fig. 50 North America: SWOT
  • Fig. 51 Europe SWOT
  • Fig. 52 Asia Pacific SWOT
  • Fig. 53 Latin America SWOT
  • Fig. 54 MEA SWOT
  • Fig. 55 North America, by country
  • Fig. 56 North America
  • Fig. 57 North America market estimates and forecast, 2018 - 2030
  • Fig. 58 U.S.
  • Fig. 59 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 60 Canada
  • Fig. 61 Canada market estimates and forecast, 2018 - 2030
  • Fig. 62 Europe
  • Fig. 63 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 64 UK
  • Fig. 65 UK market estimates and forecast, 2018 - 2030
  • Fig. 66 Germany
  • Fig. 67 Germany market estimates and forecast, 2018 - 2030
  • Fig. 68 France
  • Fig. 69 France market estimates and forecast, 2018 - 2030
  • Fig. 70 Italy
  • Fig. 71 Italy market estimates and forecast, 2018 - 2030
  • Fig. 72 Spain
  • Fig. 73 Spain market estimates and forecast, 2018 - 2030
  • Fig. 74 Sweden
  • Fig. 75 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 76 Denmark
  • Fig. 77 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 78 Norway
  • Fig. 79 Norway market estimates and forecast, 2018 - 2030
  • Fig. 80 Asia Pacific
  • Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 82 China
  • Fig. 83 China market estimates and forecast, 2018 - 2030
  • Fig. 84 Japan
  • Fig. 85 Japan market estimates and forecast, 2018 - 2030
  • Fig. 86 India
  • Fig. 87 India market estimates and forecast, 2018 - 2030
  • Fig. 88 Australia
  • Fig. 89 Australia market estimates and forecast, 2018 - 2030
  • Fig. 90 South Korea
  • Fig. 91 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 92 Thailand
  • Fig. 93 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 94 Latin America
  • Fig. 95 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 96 Brazil
  • Fig. 97 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 98 Mexico
  • Fig. 99 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 100 Argentina
  • Fig. 101 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 102 Middle East and Africa
  • Fig. 103 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 104 Saudi Arabia
  • Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 106 South Africa
  • Fig. 107 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 108 UAE
  • Fig. 109 UAE market estimates and forecast, 2018 - 2030
  • Fig. 110 Kuwait
  • Fig. 111 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 112 Participant categorization- preclinical imaging market
  • Fig. 113 Market share of key market players- preclinical imaging market